Rua commences direct distribution from Tairawhiti.
Traumatic Brain Injury Clinical Trial Funded
FY26 Financial Results: Significant Revenue Growth
Rua BIoscience Full Year Financial Results FY26
Rua enters into partnership with ancient plant
Five New Products Approved for New Zealand Market
Significant UK Distribution Agreement
Ruah Bioscience enters the UK market with a major distribution deal with a significant medicinal cannabis clinic and distribution company.
Introducing Oleo Panacea V2
Finalist in 2026 Cannabiz Awards
Europe update
Guide to Using Medicinal Cannabis in New Zealand
Market Update
Expansion into Canada with genetics export milestone
Half-Year Financial Results: Significant sales revenue growth
Rua BIoscience haf year financial results FY26
Investing in the Future of Tairawhiti: Rua Bioscience Scholarships
Darylene Rogers of Rua Bioscience acknowledges scholarship recipient Paimarire Heeney-Haua at the TKKM o Te Waiu o Ngati Porou prize giving 2025.
Successful rights offer is oversubscribed
Rua Bioscience rights offer outcome
Smoking cessation products from native plants
Strong support for pro-rata Rights Offer
New supply for the German market
Rua Bioscience strengthens supply chain into German medicinal cannabis market.
Tell Parliament: Decriminalise
Record quarterly revenue
Quarterly revenue is a record for Rua Bioscience. Sales revenue is growing significantly.